大麻使用与精神病性障碍在多巴胺系统上的汇聚
该纵向观察性队列研究于2019至2023年在加拿大伦敦市招募伴或不伴大麻使用障碍(CUD)且部分合并首发精神分裂症(FES)的个体,用黑素敏感MRI信号作为多巴胺功能代理指标。CUD与腹侧黑质/腹侧被盖区(SN/VTA)黑素敏感MRI信号升高相关并呈剂量依赖,而FES患者该信号未见显著升高。
要点
- CUD与腹侧SN/VTA黑素敏感MRI信号升高相关(387/2060体素,校正P=0.03)。
- CUD与精神病相关感兴趣区信号升高相关(t92=2.12,P=0.04),且呈剂量依赖(F1,96=4.89,P=0.03)。
- FES患者黑素敏感MRI信号未见显著升高(241个体素,校正P=0.09)。
核心结论
- 作者认为,SN/VTA关键亚区多巴胺功能升高可能与CUD患者的精神病风险相关。
- 作者认为,大麻与精神病症状临床表达的假想最终共同通路相关。
研究设计与样本
- 纵向观察性队列研究,2019至2023年从加拿大伦敦市早期精神病服务及周边社区招募参与者。
- CUD与FES诊断依据DSM-5结构化临床访谈。
- 主要结局为中脑黑质(SN)/腹侧被盖区(VTA)黑素敏感MRI信号,包括一个先前与未治疗精神病严重程度相关的亚区(预先设定的感兴趣区)。
- 采用线性混合效应分析考察黑素敏感MRI信号与临床指标的关系;CUD组12人、无CUD组25人完成1年随访。
主要发现
- CUD与一组腹侧SN/VTA体素的黑素敏感MRI信号升高相关(2060个SN/VTA体素中的387个,校正P=0.03,置换检验)。
- CUD与精神病相关感兴趣区的黑素敏感MRI信号升高相关(t92=2.12,P=0.04)。
- CUD症状负担越高,黑素敏感MRI信号越高,呈显著剂量依赖关联(F1,96=4.89,P=0.03)。
- FES患者黑素敏感MRI信号未见显著升高(241个SN/VTA体素信号升高,校正P=0.09)。
- 时间与黑素敏感MRI信号之间无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite evidence that individuals with a cannabis use disorder (CUD) are at elevated risk of psychosis and that the neurotransmitter dopamine has a role in psychosis, the mechanism linking cannabis use and psychosis remains unclear. OBJECTIVE: To use neuromelanin-sensitive magnetic resonance imaging (MRI), referred to as the neuromelanin-MRI signal, a practical, proxy measure of dopamine function, to assess whether a common alteration in the dopamine system may be implicated in CUD and psychosis and whether this alteration can be observed in those with a CUD whether or not they have a diagnosis of first-episode schizophrenia (FES). DESIGN, SETTING, AND PARTICIPANTS: This longitudinal observational cohort study recruited individuals from 2019 to 2023 from an early psychosis service and the surrounding communities in London, Ontario. The sample included individuals with and without CUD, with some in each group also diagnosed with FES. EXPOSURES: FES and CUD diagnoses from the Structured Clinical Interview for DSM-5. MAIN OUTCOMES AND MEASURES: Neuromelanin-MRI signals within the midbrain (substantia nigra [SN]/ventral tegmental area [VTA]) including a subregion previously linked to the severity of untreated psychosis (a priori region of interest). Linear mixed-effects analyses were performed relating neuromelanin-MRI signals to clinical measures. RESULTS: A total of 36 individuals without CUD (mean [SD] age, 22.3 [3.2] years; 29 male [81%]; 12 with FES) and 25 individuals with CUD (mean [SD] age, 24.3 [4.7] years; 22 male [88%]; 16 with FES) participated in the study. One-year follow-up was completed for 12 individuals with CUD and 25 without CUD. CUD was associated with elevated neuromelanin-MRI signal in a set of ventral SN/VTA voxels (387 of 2060 SN/VTA voxels, corrected P = .03, permutation test). CUD was also associated with elevated neuromelanin-MRI signal in the psychosis-related region of interest (t92 = 2.12, P = .04) with a significant dose-dependent association (higher burden of CUD symptoms associated with higher neuromelanin-MRI signal, F1, 96 = 4.89; P = .03). In contrast, participants with FES did not exhibit a significant elevation in neuromelanin-MRI signal (241 SN/VTA voxels had elevated signal, corrected P = .09). There was no association between time and neuromelanin-MRI signal. CONCLUSIONS AND RELEVANCE: Elevated dopamine function in a critical SN/VTA subregion may be associated with psychosis risk in people with CUD. Cannabis was associated with the hypothesized final common pathway for the clinical expression of psychotic symptoms.
引用
- Ahrens J, Ford SD, Schaefer B, et al. Convergence of Cannabis and Psychosis on the Dopamine System. JAMA Psychiatry. 2025. PMID: 40202728. doi:10.1001/jamapsychiatry.2025.0432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。